Saptagir Laboratories is an API manufacturer based in India. It holds 12 active US drug master files across a filed portfolio of 4 molecules. Customs aggregates show $981K of exports covering 37 molecules to 14 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Medak, India | 3016470054 |
| Molecule | Regulators | Docs |
|---|---|---|
| Ezetimibe | US FDA | 4 |
| Tafamidis | US FDA | 4 |
| Edoxaban | US FDA | 2 |
| Terbinafine | US FDA | 2 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $189K | 4 |
| 2025 | Not reported | $981K | 14 |
| 2024 | Not reported | $489K | 7 |
| 2023 | Not reported | $711K | 10 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Saptagir Laboratories comes back tiered against every other supplier able to file there.
Start for free